Rabbit anti-Human c-Met Polyclonal Antibody | anti-c-Met antibody

c-Met, CT (Hepatocyte Growth Factor Receptor, Scatter Factor Receptor, HGFR, SFR) (HRP)

Cat. Num. AAA6487837

• Reactivity: Human
• Applications: Immunohistochemistry, Western Blot
• Purity: Purified
• Synonyms: c-Met; Polyclonal Antibody; CT (Hepatocyte Growth Factor Receptor; Scatter Factor Receptor; HGFR; SFR) (HRP); anti-c-Met antibody

• Host: Rabbit
• Reactivity: Human
• Clonality: Polyclonal
• Isotype: IgG
• Specificity: Recognizes human c-Met. Detects a 45kD protein on Western Blots of A431 cell lysate.
• Purity/Purification: Purified
• Form/Format: Supplied as a liquid in PBS, pH 7.2. No preservatives added. Labeled with Horseradish Peroxidase (HRP).

• Applicable Applications for anti-c-Met antibody: Immunohistochemistry (IHC) Frozen/Paraffin, Western Blot (WB)
• Application Notes: IHC-F/P: Frozen and formalin-fixed paraffin-embedded sections. Epitope retrieval required using citrate buffer, pH 6.0 is required. Enzyme digestion is not required.; Applications are based on unconjugated antibody.
• Immunogen: Synthetic peptide derived from the human c-Met C-terminus sequence, conjugated to a carrier protein. Expected Staining Pattern: Cytoplasmic
• Conjugate: HRP
• Positive Control: Breast carcinoma
• Note: Preservative Free
• Preparation and Storage: Store product at 4 degree C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20 degree C. Aliquots are stable at -20 degree C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Note: Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates.

Product Categories/Family for anti-c-Met antibody

Antibodies; Growth Factors; Cytokines

References

1. To, C.T., Tsao, M.S., The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). Oncol Rep 5(5): 1013-24 (1998). 2. Camp, R.L., Rimm, E.B., Rimm, D.L., Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 86(11): 2259-65 (1999). 3. Nakajima, M., et al., The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85(9): 1894-902 (1999). 4. Wagatsuma, S., et al., Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82(3): 520-30 (1998). 5. Elias, J.M., et al., Sensitivity and Detection Efficiency of the PAP, ABC and LAB Methods. Am. J. Clin. Pathol. 92: 62-67 (1989). 6. Shi, Z.R., Itzkowitz, S.H., Kim, Y.S., A Comparison of Three Immunoperoxidase Techniques for Antigen Detection in Colorectal Carcinoma Tissues. J. Histochemistry and Cytochemistry 36(3): 317-322 (1988). 7. Kiernan, J.A., Histological and Histochemical Methods: Theory and Practice. New York: Pergamon Press (1981). 8. Sheehan, D.C., Hrapchak, B.B., Theory and Practice of Histotechnology. St. Louis: C.V. Mosby Co. (1980). 9. Taylor, Cote, Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist. 2nd Ed. W.B. Saunders Co. Philadelphia, (1994). 10. Elias, J.M., et al., Special Report: Quality Control in immunohistochemistry. Am. J. Clin. Path. 92: 836 (1989). 11. O'Leary, T.J., et al., Quality assurance for immunocytochemistry: Proposed guideline MM4-P. National Committee for Clinical Laboratory Standards (NCCLS). Wayne, PA. 1-46. (1997). 12. College of American Pathologists (CAP) Certification Program for Immunohistochemistry. Northfield, IL. Http://www.cap.org (800) 323-4040. 13. Clinical Laboratory Improvement Amendments of 1988: Final Rule, 57 FR 7163 (February 28, 1992. ) 14. Koretzik, K., et al., Metachromasia of AEC and its precision in immunoperoxidase techniques. Histochemistry. 86: 471-478. (1987).